The partial efficacy reported in the RV144 HIV vaccine trial in 2009 has driven the HIV vaccine field to define correlates of risk associated with HIV-1 acquisition and connect these functionally to preventing HIV infection. Immunological correlates, mainly including CD4(+) T cell responses to the H...
Research Assistant
AI chat, annotations, notes & similar papers
No comments yet
Be the first to share your thoughts!